Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 2
2015 3
2016 1
2017 1
2018 1
2019 2
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Radioimmunoconjugates for treating cancer: recent advances and current opportunities.
Bourgeois M, Bailly C, Frindel M, Guerard F, Chérel M, Faivre-Chauvet A, Kraeber-Bodéré F, Bodet-Milin C. Bourgeois M, et al. Among authors: frindel m. Expert Opin Biol Ther. 2017 Jul;17(7):813-819. doi: 10.1080/14712598.2017.1322577. Epub 2017 May 4. Expert Opin Biol Ther. 2017. PMID: 28438082 Review.
[Place of molecular imaging in the management of prostate cancer].
Rousseau C, Le Thiec M, Maucherat B, Frindel M, Fleury V. Rousseau C, et al. Among authors: frindel m. Cancer Radiother. 2021 Oct;25(6-7):663-666. doi: 10.1016/j.canrad.2021.07.032. Epub 2021 Aug 14. Cancer Radiother. 2021. PMID: 34404605 Review. French.
ARRONAX Cyclotron: Setting up of In-House Hospital Radiopharmacy.
Vidal A, Bourdeau C, Frindel M, Garcia T, Haddad F, Faivre-Chauvet A, Bourgeois M. Vidal A, et al. Among authors: frindel m. Biomed Res Int. 2020 Mar 10;2020:1572841. doi: 10.1155/2020/1572841. eCollection 2020. Biomed Res Int. 2020. PMID: 32566657 Free PMC article.
Preliminary results of a 68 Ga-PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision-making.
Rousseau C, Le Thiec M, Ferrer L, Rusu D, Rauscher A, Maucherat B, Frindel M, Baumgartner P, Fleury V, Denis A, Morel A, Varmenot N, Debeaupuis E, Campion L, Kraeber-Bodéré F. Rousseau C, et al. Among authors: frindel m. Prostate. 2019 Sep;79(13):1514-1522. doi: 10.1002/pros.23869. Epub 2019 Aug 17. Prostate. 2019. PMID: 31421657 Clinical Trial.
68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes.
Barbaud M, Frindel M, Ferrer L, Le Thiec M, Rusu D, Rauscher A, Maucherat B, Baumgartner P, Fleury V, Colombié M, Thierry-Morel A, Kraeber-Bodéré F, Campion L, Rousseau C. Barbaud M, et al. Among authors: frindel m. Prostate. 2019 Apr;79(5):454-461. doi: 10.1002/pros.23751. Epub 2018 Dec 14. Prostate. 2019. PMID: 30549066
Improvement of the Targeting of Radiolabeled and Functionalized Liposomes with a Two-Step System Using a Bispecific Monoclonal Antibody (Anti-CEA × Anti-DTPA-In).
Rauscher A, Frindel M, Rajerison H, Gouard S, Maurel C, Barbet J, Faivre-Chauvet A, Mougin-Degraef M. Rauscher A, et al. Among authors: frindel m. Front Med (Lausanne). 2015 Nov 25;2:83. doi: 10.3389/fmed.2015.00083. eCollection 2015. Front Med (Lausanne). 2015. PMID: 26636087 Free PMC article.
12 results